TNF¿-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry Carolina Ayelen Isnardi; Emma Estela Civit De Garignani; Agustín García Ciccarelli; Jimena Sanchez Alcover; Ingrid Strusberg; Marcos Baravalle; Sol Castaños; Liliana Morales; Matias Palombo; Eduardo Albiero; Carla Gobbi; Rodrigo Garcia Salinas; Sebastian Magri; Edson Velozo; Enrique R. Soriano; Alfredo Vargas Caselles; Luis Carlos Palomino Romero; Sergio Paira; Romina Calvo; Alberto Ortiz; María Julieta Gamba; Rodolfo Perez Alamino; Hernan Maldonado Ficco; Gustavo Citera;

Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis José María Álvaro-Gracia Álvaro; Petra Díaz del Campo Fontecha; José Luis Andréu Sánchez; Alejandro Balsa Criado; Rafael Cáliz Cáliz; Isabel Castrejón Fernández; Hèctor Corominas; José A. Gómez Puerta; Sara Manrique Arija; Natalia Mena Vázquez; Ana Ortiz García; Chamaida Plasencia Rodríguez; Lucía Silva Fernández; Jesús Tornero Molina;

Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;